GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Cyclically Adjusted Price-to-FCF

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Cyclically Adjusted Price-to-FCF : (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Price-to-FCF Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF falls into.



Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Luoxin Pharmaceuticals Group Stock Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.09/115.2271*115.2271
=-0.090

Current CPI (Mar. 2024) = 115.2271.

Luoxin Pharmaceuticals Group Stock Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201212 0.000 95.237 0.000
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201503 -0.038 99.900 -0.044
201506 0.048 99.500 0.056
201509 -0.156 100.500 -0.179
201512 0.211 100.600 0.242
201603 -0.010 102.200 -0.011
201606 -0.007 101.400 -0.008
201609 -0.131 102.400 -0.147
201612 0.158 102.600 0.177
201703 -0.129 103.200 -0.144
201706 -0.147 103.100 -0.164
201709 -0.045 104.100 -0.050
201712 0.165 104.500 0.182
201803 -0.210 105.300 -0.230
201806 0.143 104.900 0.157
201809 -0.168 106.600 -0.182
201812 -0.344 106.500 -0.372
201903 -0.608 107.700 -0.650
201906 0.079 107.700 0.085
201909 0.073 109.800 0.077
201912 0.003 111.200 0.003
202003 -0.159 112.300 -0.163
202006 -0.132 110.400 -0.138
202009 -0.129 111.700 -0.133
202012 0.154 111.500 0.159
202103 -0.202 112.662 -0.207
202106 0.023 111.769 0.024
202109 -0.172 112.215 -0.177
202112 0.232 113.108 0.236
202203 -0.678 114.335 -0.683
202206 -0.044 114.558 -0.044
202209 -0.269 115.339 -0.269
202212 0.187 115.116 0.187
202303 -0.013 115.116 -0.013
202306 0.081 114.558 0.081
202309 0.079 115.339 0.079
202312 0.064 114.781 0.064
202403 -0.090 115.227 -0.090

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Luoxin Pharmaceuticals Group Stock Co  (SZSE:002793) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Traded in Other Exchanges
N/A
Address
85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Executives
Ye Bang Mi Supervisors
Fang Xiu Bao Directors, executives
Zhu Fu Lin Directors, executives
Chen Li Supervisors
Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines